Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combining mechanism-based prediction with patient-based profiling for psoriasis metabolomics biomarker discovery.

AMIA ... Annual Symposium proceedings. AMIA Symposium - 1 Jan 2017

Wang QuanQiu, McCormick Thomas S, Ward Nicole L, Cooper Kevin D, Conic Ruzica, Xu Rong

Abstract excerpt

Psoriasis is a chronic, debilitating skin condition that affects approximately 125 million individuals worldwide. The cause of psoriasis appears multifactorial, and no unified mitigating signal or single antigenic target has been identified to date. Metabolomic studies hold great potential for explaining disease mechanism, facilitating early diagnosis, and identifying potential therapeutic areas. Here, we present...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Disease Models, Animal

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genome

Share to Metabolome

Share to Metabolomics

Share to Phenotype

Share to Psoriasis

Source

Open in PubMed Open full text

Identifiers

PMID: 29854244
PMCID: PMC5977692

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combining mechanism-based prediction with patient-based profiling for psoriasis metabolomics biomarker discovery.PMID 29854244Read ↗

Metabolomics reveals molecular signatures for psoriasis biomarkers and drug targets discoverySemantic proximity Read ↗

Metabolomics in psoriatic disease: pilot study reveals metabolite differences in psoriasis and psoriatic arthritisSemantic proximity Read ↗

Multi-Omics Research Strategies for Psoriasis and Atopic DermatitisSemantic proximity Read ↗

Uncovering metabolite-immune interactions in the pathogenesis of psoriatic arthritis: A 2-sample Mendelian randomization study.Semantic proximity Read ↗

Genetic causality and metabolite pathway identifying the relationship of blood metabolites and psoriasis.Semantic proximity Read ↗

Omics-Driven Biomarkers of Psoriasis: Recent Insights, Current Challenges, and Future ProspectsSemantic proximity Read ↗

Global Prioritization of Disease Candidate Metabolites Based on a Multi-omics Composite Network.Semantic proximity Read ↗

Research progress and perspective in metabolism and metabolomics of psoriasis.Semantic proximity Read ↗

Mendelian randomization linking metabolites with enzymes reveals known and novel pathway regulation and therapeutic avenuesSemantic proximity Read ↗

Mendelian randomization linking metabolites with enzymes reveals pathway regulation and therapeutic avenues.Semantic proximity Read ↗

Identification of potential causal metabolites associated with atopic dermatitis.Semantic proximity Read ↗

Knowledge-Driven Approaches to Create the MTox700+ Metabolite Panel for Predicting Toxicity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.